<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940413-2-00098</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <TABLE>  <!-- PJG tableformat 3,L2,tp0,i1,s100,15,15  -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Basic class  <!-- PJG 007 0150 intable --> 1Previously established 1994 aggregate production quotas  <!-- PJG 007 0150 intable --> 1Proposed revised 1994 aggregate production quotas <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Schedule I: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> 2,5-Dimethoxyamphetamine  <!-- PJG 007 0104 intable --> 15,400,000  <!-- PJG 007 0104 intable --> 15,510,000 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> Schedule II: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=1 --> Alfentanil  <!-- PJG 007 0104 intable --> 7,110  <!-- PJG 007 0104 intable --> 8,000 <!-- PJG 0012 frnewline --> Amphetamine  <!-- PJG 007 0104 intable --> 359,000  <!-- PJG 007 0104 intable --> 469,000 <!-- PJG 0012 frnewline --> Codeine (for sale)  <!-- PJG 007 0104 intable --> 64,235,000  <!-- PJG 007 0104 intable --> 58,127,000 <!-- PJG 0012 frnewline --> Desoxyephedrine  <!-- PJG 007 0104 intable --> 22,100  <!-- PJG 007 0104 intable --> 11,000 <!-- PJG 0012 frnewline --> Diphenoxylate  <!-- PJG 007 0104 intable --> 1,023,000  <!-- PJG 007 0104 intable --> 638,000 <!-- PJG 0012 frnewline --> Levorphanol  <!-- PJG 007 0104 intable --> 6,400  <!-- PJG 007 0104 intable --> 7,400 <!-- PJG 0012 frnewline --> Methylphenidate  <!-- PJG 007 0104 intable --> 5,300,000  <!-- PJG 007 0104 intable --> 6,924,000 <!-- PJG 0012 frnewline --> Opium  <!-- PJG 007 0104 intable --> 1,242,000  <!-- PJG 007 0104 intable --> 688,000 <!-- PJG 0012 frnewline --> Oxycodone (for sale)  <!-- PJG 007 0104 intable --> 4,312,000  <!-- PJG 007 0104 intable --> 2,995,000 <!-- PJG 0012 frnewline --> Oxycodone (for conversion)  <!-- PJG 007 0104 intable --> 3,400  <!-- PJG 007 0104 intable --> 5,400 <!-- PJG 0012 frnewline --> Oxymorphone  <!-- PJG 007 0104 intable --> 1,400  <!-- PJG 007 0104 intable --> 2,420 <!-- PJG 0012 frnewline --> Pentobarbital  <!-- PJG 007 0104 intable --> 14,430,000  <!-- PJG 007 0104 intable --> 15,000,000 <!-- PJG 0012 frnewline --> Phencyclidine  <!-- PJG 007 0104 intable --> 32  <!-- PJG 007 0104 intable --> 52 <!-- PJG 0012 frnewline --> Secobarbital  <!-- PJG 007 0104 intable --> 550,000  <!-- PJG 007 0104 intable --> 338,000 <!-- PJG 0012 frnewline --> Sufentanil  <!-- PJG 007 0104 intable --> 620  <!-- PJG 007 0104 intable --> 870 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> All interested persons are invited to submit their comments and objections in writing regarding this proposal. A person may object to or comment on the proposal relating to any of the above mentioned substances without filing comments or objections regarding the others. If a person believes that one or more of these issues warrant a hearing, the individual should so state and summarize the reasons for this belief. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> In the event that comments or objections to this proposal raise one or more issues which the Administrator finds warrant a hearing, the Administrator shall order a public hearing by notice in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , summarizing the issues to be heard and setting the time for the hearing. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The Office of Management and Budget has determined that notice of aggregate production quotas are not subject to centralized review under Executive Order 12866. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Rules establishing aggregate production quotas for controlled substances in Schedules I and II are required by statute, fulfill United States obligations under the Single Convention on Narcotic Drugs, 1961, and other international treaties, and are essential to a criminal law enforcement function of the United States. Without the periodic establishment and adjustment of aggregate production quotas, pharmaceutical manufacturers in the United States could not lawfully produce a wide variety of medically necessary pharmaceutical drugs. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> These actions have been analyzed in accordance with the principles and criteria contained in Executive Order 12612 and it has been determined that this matter raises no Federalism implications which would warrant the preparation of a Federalism Assessment. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The Administrator hereby certifies that this action will have no significant impact upon small entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq. The establishment and revision of annual production quotas for Schedules I and II controlled substances is mandated by law and by the international obligations of the United States. Such quotas impact predominantly upon major manufacturers of the affected controlled substances. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: April 5, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Thomas A. Constantine, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Administrator. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;8784 Filed 4&hyph;12&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4410&hyph;09&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            